Found: 4
Select item for more details and to access through your institution.
Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 12047, doi. 10.1007/s00432-023-05059-5
- By:
- Publication type:
- Article
TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease‐free survival.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 8, p. 1, doi. 10.1002/jmv.29043
- By:
- Publication type:
- Article
Worse Wilms’ Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2024, v. 21, n. 5, p. 439, doi. 10.21873/cgp.20462
- By:
- Publication type:
- Article
Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 4, p. 575, doi. 10.3390/biology12040575
- By:
- Publication type:
- Article